A mechanistic model of effects of dioxin on thyroid hormones in the rat

Toxicology and Applied Pharmacology

Volumn 136, Issue 1, 1996, Pages 29-48

  Kohn, Michael C ^a   Sewall, Charles H ^a   Lucier, George W ^a   Portier, Christopher J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DIOXIN; GLUCURONOSYLTRANSFERASE; IODOTHYRONINE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOSIMETRY; HYPOPHYSIS; KIDNEY; LIVER; MODEL; NONHUMAN; RAT; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0030033462     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0004     Document Type: Article

References (90)

1. Abraham, M. H., Kamlet, M. J., Taft, R. W., Doherty, R. M., and Weathersby, P. K. (1985). Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of nonelectrolytes in biological tissues and fluids. J. Med. Chem. 28, 865-870.
2. Abraham, K., Krowke, R., and Neubert, D. (1988). Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Toxicol. 62, 359-368.
3. Albro, P. W., Corbett, J. T., Harris, M., and Lawson, L. D. (1978). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid profiles in tissue of the Fischer rat. Chem.-Biol. Interact. 23, 315-330.
4. Altman, P. L., and Dittmer, D. S. (Eds.) (1971). Respiration and Circulation, pp. 384-385. Fed. Am. Soc. Exp. Biol., Bethesda, MD.
5. Andersen, M. E., Mills, J. J., Gargas, M. L., Kedderis, L., Birnbaum, L. S., Neubert, D., and Greenlee, W. F. (1993). Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk Anal. 13, 25-36.
6. Andrae, U., and Greim, H. (1992). Initiation and promotion in thyroid carcinogenesis. In Tissue Specific Toxicity: Biochemical Mechanisms, pp. 71-93. Academic Press, New York.
7. Aprilletti, J. W., David-Inouye, Y., Baxter, J. D., and Eberhardt, N. L. (1987). Physicochemical characterization of the intranuclear thyroid hormone receptor. In Molecular Basis of Thyroid Hormone Action (J. H. Oppenheimer and H. H. Samuels, Eds.), pp. 67-97. Academic Press, New York.
8. Bank, P., Salyers, K. L., and Zile, M. H. (1989). Effect of tetrachlorodibenzo-p-dioxin (TCDD) on the glucuronidation of retinoic acid in the rat. Biochim. Biophys. Acta 993, 1-6.
9. Barnes, C. P., and DeGroot, L. J. (1987). Nuclear-cytoplasmic interrelationships. In Molecular Basis of Thyroid Hormone Action (J. H. Oppenheimer and H. H. Samuels, Eds.), pp. 139-177. Academic Press, New York.
10. Barter, R. A., and Klaassen, C. D. (1992a). UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicol. Appl. Pharmacol. 113, 36-42.
11. Barter, R. A., and Klaassen, C. D. (1992b). Rat liver microsomal UDP-glucuronosyltransferase activity toward thyroxine: Characterization, induction, and form specificity. Toxicol. Appl. Pharmacol. 115, 261-267.
12. Bastomsky, C. H. (1977). Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology 101, 292-296.
13. Berry, M. J., and Larsen, P. R. (1992). The role of selenium in thyroid hormone action. Endocr. Rev. 13, 207-219.
14. Bock, K. W. (1991). Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 26, 129-150.
15. Bischoff, K. B., and Brown, R. G. (1966). Drug distribution in mammals. Chem. Eng. Prog. Symp. Ser. 62, 33-45.
16. Brent, R. P. (1973). Algorithms for Minimization without Derivatives. Prentice-Hall, Englewood Cliffs, NJ.
17. Capen, C. C. (1992). Pathophysiology of chemical injury of the thyroid gland. Toxicol. Lett. 64/65, 381-388.
18. 3 in the rat. J. Clin. Invest. 91, 2709-2713.
19. Chopra, I. J. (1991). New insights into thyroid hormone deiodination. In Thyroid Hormone Metabolism (S.-Y. Wu, Ed.), pp. 41-54. Blackwell Sci., Boston.
20. Clark, G., Tritscher, A., Maronpot, R., Foley, J., and Lucier, G. (1991). Tumor Promotion by TCDD in Female Rats. In Banbury Report 35: Biological Basis for Risk Assessment of Dioxins and Related Compounds, pp. 389-404. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Coughtrie, M. W. H., Burchell, B., and Bend, J. R. (1987). Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochem. Pharmacol. 36, 245-251.
22. Delp, M. D., Manning, R. O., Bruckner, J. V., and Armstrong, R. B. (1991). Distribution of cardiac output during diurnal changes of activity in rats. Am. J. Physiol. 261, H1487-H1493.
23. Ekins, R. (1986). The free hormone concept. In Thyroid Hormone Metabolism (G. Hennemann, Ed.), pp. 77-106. Dekker, New York.
24. Eltom, S. E., Babish, J. G., and Ferguson, D. C. (1992). The interaction of L-triiodothyronine and 2,3,7,8-tetrachlorodibenzo-p-dioxin on Ah-receptor-mediated hepatic phase I and phase II enzymes and iodothyronine 5′-deiodinase in thyroidectomized rats. Toxicol. Lett. 61, 125-139.
25. Fingerhut, M. A., Halperin, W. E., Marlow, D. A., Piacitelli, L. A., Honchar, P. A., Sweeny, M. H., Griefe, A. L., Dill, P. A., Steenland, K., and Suruda, H. (1991). Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 324, 212-218.
26. Fiserova-Bergerova, V., and Diaz, M. L. (1986). Determination and prediction of tissue-gas partition coefficients. Int. Arch. Occup. Environ. Health 58, 75-87.
27. Fisher, J. M., Wu, L., Denison, M. S., and Whitlock, J. P. (1990). Organization and function of a dioxin-responsive enhancer. J. Biol. Chem. 265, 9676-9681.
28. Fouts, J. R., and Devereux, T. R. (1973). Use of 10-sec sonication of homogenates to increase microsomal protein yield in liver and lung from young and adult Dutch Belt rabbits. Biochem. Pharmacol. 22, 1393-1396.
29. Gasiewicz, T. A., Geiger, L. E., Rucci, G., and Neal, R. A. (1983). Distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J and B6D2F1/J mice. Drug Metab. Dispos. 11, 397-403.
30. Gershengorn, M. C. (1983). Thyroid hormone regulation of thyrotropin production and interaction with thyrotropin releasing hormone in thyrotropic cells in culture. In Molecular Basis of Thyroid Hormone Action (J. H. Oppenheimer and H. H. Samuels, Eds.), pp. 378-412. Academic Press, New York.
31. Gorski, J., Muzi, G., Weber, L. W. D., Pereira, D. W., Arceo, R. J., Iatropoulos, M. J., and Rozman, K. (1988). Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Pathol. 16, 313-320.
32. Gorski, J. R., and Rozman, K. (1987). Dose-response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicology 44, 297-307.
33. Goswami, A., and Rosenberg, I. N. (1985). Purification and characterization of a cytosolic protein enhancing GSH-dependent microsomal iodothyronine 5′-monodeiodination. J. Biol. Chem. 260, 6012-6019.
34. Harper, H. A., Rodwell, V. W., and Mayes, P. A. (1977). Review of Physiological Chemistry, p. 464. Lange Medical Pub., Los Altos, CA.
35. Henry, E. C., and Gasiewicz, T. A. (1987). Changes in thyroid hormones and thyroxine glucuronidation in hamsters compared with rats following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 89, 165-174.
36. Hill, R. N., Erdreich, L. S., Paynter, O. E., Roberts, P. A., Rosenthal, S. L., and Wilkinson, C. F. (1989). Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12, 629-697.
37. Hook, G. E. R., Haseman, J. K., and Lucier, G. W. (1975). Induction and suppression of hepatic and extrahepatic microsomal foreign-compound-metabolizing enzyme systems by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem.-Biol. Interact. 10, 199-214.
38. Hotta, H., Ooka, H., and Sato, A. (1991). Changes in basal secretion rates of thyroxine and 3,3′,5-triiodothyronine from the thyroid gland during aging of the rat. Jpn. J. Physiol. 41, 75-84.
39. Huff, J. E., Salmon, A. G., Hooper, N. K., and Zeise, L. (1991). Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins. Cell Biol. Toxicol. 7, 67-94.
40. Johnson, E. S. (1993). Important aspects of the evidence for TCDD carcinogenicity in man. Environ. Health Perspect. 99, 383-390.
41. Kedderis, L. B., Mills, J. J., Andersen, M. E., and Birnbaum, L. S. (1993). A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin in the rat: Tissue distribution and CYPiA induction. Toxicol. Appl. Pharmacol. 121, 87-98.
42. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel, R. A., and Humiston, C. G. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
43. Kohn, M. C., Hines, M. L., Kootsey, J. M., and Feezor, M. D. (1994a). A block organized model builder. Mathl. Comput. Modelling 19, 75-97.
44. Kohn, M. C., Lucier, G. W., Clark, G. C., Sewall, C., Tritscher, A. M., and Portier, C. J. (1993). A mechanistic model of effects of dioxin on gene expression in the rat liver. Toxicol. Appl. Pharmacol. 120, 138-154.
45. Kohn, M. C., Lucier, G. W., and Portier, C. J. (1994b). The importance of biological realism in dioxin risk assessment models. Risk Anal. 14, 993-1000.
46. Kootsey, J. M., Kohn, M. C., Feezor, M. D., Mitchell, G. R., and Fletcher, P. R. (1986). SCoP: An interactive simulation control program for micro-and minicomputers. Bull. Math. Biol. 48, 427-441.
47. Krenning, E., Docter, R., Bernard, B., Visser, T., and Hennemann, G. (1981). Characteristics of active transport of thyroid hormone into rat hepatocytes. Biochim. Biophys. Acta 676, 314-320.
48. Labrie, F., DeLéan, A., Lagrace, L., Drouin, J., Beaulieu, M., and Morin, O. (1978). Interactions of TRH, LH-RH, and somatostatin in the anterior pituitary gland. In Receptors and Hormone Action (L. Birnbaumer and B. W. O'Malley, Eds.), Vol. III, pp. 493-514. Academic Press, New York.
49. Landis, E. M., and Pappenheimer, J. R. (1963). Exchange of substances through the capillary walls. In Handbook of Physiology (W. F. Hamilton, Ed.), Sec. 2, Vol. 2, pp. 961-1034. Am. Physiol. Soc., Washington, DC.
50. Larsen, P. R., Silva, J. E., and Kaplan, M. M. (1981). Relationships between circulating and intracellular thyroid hormones: Physiological and clinical implications. Endocr. Rev. 2, 87-102.
51. Latham, K. R., MacLeod, K. M., Papavasiliou, S. S., Martial, J. A., Seeburg, P. H., Goodman, H. M., and Baxter, J. D. (1978). Regulation of gene expression by thyroid hormones. In Receptors and Hormone Action (L. Birnbaumer and B. W. O'Malley, Eds.), Vol. III, pp. 75-100. Academic Press, New York.
52. Leonard, J. L. (1991). Biochemical basis of thyroid hormone deiodination. In Thyroid Hormone Metabolism (S.-Y. Wu, Ed.), pp. 1-28. Blackwell Sci., Boston.
53. Leonard, J. L., and Visser, T. J. (1986). Biochemistry of deiodination. In Thyroid Hormone Metabolism (G. Hennemann, Ed.), pp. 189-229. Dekker, New York.
54. Leung, H.-W., Paustenbach, D. J., Murray, F. J., and Andersen, M. E. (1990). A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol. Appl. Pharmacol. 103, 399-410.
55. Lucier, G., Clark, G., Hiermath, C., Tritscher, A., Sewall, C., and Huff, J. (1993). Carcinogenicity of TCDD in laboratory animals: Implications for risk assessment. Toxicol. Industrial Health 9, 631-666.
56. Lucier, G. W., McDaniel, O. S., Hook, G. E. R., Fowler, B. A., Sonawane, B. R., and Faeder, E. (1973). TCDD-induced changes in rat liver microsomal enzymes. Environ. Health Perspect. 5, 199-209.
57. Lucier, G. W., Rumbaugh, R. C., McCoy, Z., Hass, R., Harvan, D., and Albro, P. (1986). Ingestion of soil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic enzyme activities in rats. Fundam. Appl. Toxicol. 6, 364-371.
58. Lucier, G. W., Tritscher, A., Goldsworthy, T., Foley, J., Clark, G., Goldstein, J., and Maronpot, R. (1991). Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for hepatocarcinogenesis. Cancer Res. 51, 1391-1397.
59. Lyman, W. J., Reehl, W. F., and Rosenblatt, D. H. (1990). Handbook of Chemical Property Estimation Methods, Am. Chem. Soc., Washington, DC. pp. 1-27.
60. Manz, A., Berger, J., Dwyer, J. H., Flesch-Janys, D., Nagel, S., and Waltsgott, H. (1991). Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338, 959-964.
61. Maronpot, R. R., Foley, J. F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A., Portier, C., and Lucier, G. (1993). Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: Histologic, biochemical, and cell proliferation endpoints. Environ. Health Perspect. 101, 634-642.
62. McClain, R. M. (1989). The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicol. Pathol. 17, 294-306.
63. McKinney, J. D., Chae, K., Oatley, S. J., and Blake, C. C. F. (1985). Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin. J. Med. Chem. 28, 375-381.
64. Mendel, C. M., Cavalieri, R. R., Gavin, L. A., Petterson, T., and Inoue, M. (1989). Thyroxine transport and distribution in Nagase analbuminemic rats. J. Clin. Invest. 83, 143-148.
65. National Toxicology Program (1982). Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Osborne-Mendel Rats and B6C3F1 Mice. National Toxicology Program Technical Report No. 209, Research Triangle Park, NC.
66. Nunez, J., and Pommier, J. (1982). Formation of thyroid hormones. Vitamin Horm. 39, 175-229.
67. Oppenheimer, J. H. (1983). The nuclear receptor-triiodothyronine complex: Relationship to thyroid hormone distribution, metabolism, and biological action. In Molecular Basis of Thyroid Hormone Action (J. H. Oppenheimer, Ed.), pp. 1-34. Academic Press, New York.
68. Oppenheimer, J. H., and Suks, M. I. (1974). Quantitative aspects of hormone production, distribution, metabolism, and activity. In Handbook of Physiology, sec. 7: Endocrinology (M. A. Greer and D. H. Solomon, Eds.), Vol. III, pp. 197-214. Am. Physiol. Soc., Washington, DC.
69. Pardridge, W. M. (1981). Transport of protein-bound hormones into tissues in vivo. Endocr. Rev. 2, 103-123.
70. Pardridge, W. M., and Mietus, L. J. (1980). Influx of thyroid hormones into rat liver in vivo. J. Clin. Invest. 66, 367-374.
71. Piva, F., and Steiner, H. (1972). Bioassay and toxicology of TRH. Front. Horm. Res. 1, 11-21.
72. Pohjanvirta, R., Kulju, T., Morselt, A. F. W., Tuominen, R., Juvonen, R., Rozman, K., Männisto, P., Collan, Y., Sainio, E.-L., and Tuomisto, J. (1989). Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain. Fundam. Appl. Toxicol. 12, 272-590.
73. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
74. Ramsden, D. B. (1978). Peripheral Metabolism and Action of Thyroid Hormones, p. 28. Eden Press, Montreal.
75. Robbins, J., and Johnson, M. L. (1979). Theoretical considerations in the transport of the thyroid hormones in blood. In Free Thyroid Hormones (R. Ekins, G. Faglia, F. Pennisi, and A. Pinchera, Eds.), pp. 1-16. Exerpta Medica, Amsterdam.
76. Rose, J. Q., Ramsey, J. C., Wentzler, T. H., Hummel, R. A., and Gehring, P. J. (1976). The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. Toxicol. Appl. Pharmacol. 36, 209-226.
77. Saito, K., Kaneko, H., Sato, K., Yoshitake, A., and Yamada, H. (1991). Heaptic UDP-glucurony-transferase(s) activity toward thyroid hormones in rats: Induction and effects on serum thyroid hormone levels following treatment with various enzyme inducers. Toxicol. Appl. Pharmacol. 111, 99-106.
78. Segal, J., and Ingbar, S. H. (1986). Extranuclear receptors for thyroid hormones. In Thyroid Hormone Metabolism (G. Hennemann, Ed.), pp. 417-439. Dekker, New York.
79. Sewall, C. H., Flagler, N., Vanden Heuvel, J. P., and Lucier, G. W. (1995). Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 132, 237-244.
80. Sewall, C., Lucier, G., Tritscher, A., and Clark, G. (1993). Dose-response relationships for TCDD-mediated changes in hepatic EGF receptor in an initiation-promotion model for hepatocarcinogenesis in female rats. Carcinogenesis 14, 1885-1893.
81. Shoemaker, W. J., Peterfreund, R. A., and Vale, W. (1983). Methodological considerations in culturing peptidergic neurons. Methods Enzymol. 103, 347-362.
82. Sloop, T. C., and Lucier, G. W. (1987). Dose-dependent elevation of Ah receptor binding by TCDD in rat liver. Toxicol. Appl. Pharmacol. 88, 329-337.
83. Spira, O., and Gordon, A. (1986). Thyroid hormone feedback effects on thyroid-stimulating hormone. In Thyroid Hormone Metabolism (G. Hennemann, Ed.), pp. 535-578. Dekker, New York.
84. Tajima, K., Mashita, K., Shimizu, M., and Tarui, S. (1985). Inhibitory effect of iopanoic acid on the thyrotropin-stimulated release of cyclic adenosine 3′,5′-monophosphate and of 3,5,3′-triiodothyronine from perifused rat thyroids. Endocrinology 117, 1813-1817.
85. Tal, E., Kovács, Zs., Korányi, L., and Endröczi, E. (1986). Morphine induced thyroxine release from rat thyroid gland in vitro. Horm. Metabol. Res. 18, 238-240.
86. Tritscher, A. M., Goldstein, J. A., Portier, C. J., McCoy, Z., Clark, G. C., and Lucier, G. W. (1992). Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52, 3436-3442.
87. Vanden Heuvel, J. P., Clark, G. C., Kohn, M. C., Tritscher, A. M., Greenlee, W. F., Lucier, G. W., and Bell, D. A. (1994). Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54, 62-68.
88. Van Middlesworth, L. (1974). Metabolism and excretion of thyroid hormones. In Handbook of Physiology, sec. 7: Endocrinology (M. A. Greer and D. H. Solomon, Eds.), Vol. III, pp. 215-231. Am. Physiol. Soc., Washington, DC.
89. Visser, T. J., Kaplan, M. M., Leonard, J. L., and Larsen, P. R. (1983). Evidence for two pathways of iodothyronine 5′-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71, 992-1002.
90. Wolfe, W., Michalek, J., Miner, J., Pirkle, J., Caudill, S., Needham, L., and Patterson, D. (1993). Dioxin half-life in veterans of Operation Ranch Hand. Organohalogen Compounds 10, 239-242.